Preventing acute gout when starting allopurinol therapy
- 1 August 1993
- journal article
- common problems
- Published by AMPCo in The Medical Journal of Australia
- Vol. 159 (3) , 182-184
- https://doi.org/10.5694/j.1326-5377.1993.tb137784.x
Abstract
Acute gout is a well known complication of the commencement of allopurinol therapy. Prophylaxis is needed for some months, even after serum urate levels have returned to normal. Colchicine is usually preferable to NSAIDs for this purpose, being cheaper, and better tolerated, especially in patients with peptic ulcer, gastrointestinal bleeding or dyspepsia or who are taking anticoagulants.Keywords
This publication has 6 references indexed in Scilit:
- Epidemiologic Evidence on the Association Between Peptic Ulceration and Antiinflammatory Drug UseGastroenterology, 1989
- Therapy in GoutRheumatic Disease Clinics of North America, 1988
- Therapeutic usage of the non‐steroidal anti‐inflammatory drugsThe Medical Journal of Australia, 1988
- DOES COLCHICINE WORK? THE RESULTS OF THE FIRST CONTROLLED STUDY IN ACUTE GOUTAustralian and New Zealand Journal of Medicine, 1987
- Treatment of goutDrug and Therapeutics Bulletin, 1985
- The efficacy of colchicine prophylaxis in articular gout—A reappraisal after 20 yearsSeminars in Arthritis and Rheumatism, 1982